You are viewing: UK Artificial Intelligence (AI) in Medical Diagnostics Market analysis

The UK Artificial Intelligence (AI) in Medical Diagnostics Market was valued at $75.8 Million in 2024 and projected to reach to $190.7 Million by 2029, representing a compound annual growth rate of 20.3%. The UK artificial intelligence in medical diagnostics market is poised for substantial expansion over the next five years, driven by NHS digitisation programmes, increasing adoption of AI-powered imaging and pathology solutions, and growing clinical validation of diagnostic AI tools.

UK Artificial Intelligence (AI) in Medical Diagnostics Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Artificial Intelligence (AI) in Medical Diagnostics Market Trends and Insights

  • The UK's advanced healthcare infrastructure, coupled with significant investment in digital health technologies, positions the nation as a key hub for AI-driven diagnostic innovation.
  • The UK's National Health Service (NHS) and private healthcare providers are increasingly adopting AI solutions for pathology, radiology, and oncology diagnostics, driving market expansion. The UK market benefits from strong regulatory frameworks, including MHRA oversight and NICE guidance on AI technologies, which foster both innovation and clinical adoption.
  • Between 2024 and 2029, the UK is expected to see accelerated deployment of machine learning algorithms for early disease detection and precision medicine applications.
  • The UK's emphasis on real-world evidence generation and integration of AI into clinical workflows supports sustained market growth throughout the forecast period..

Key Market Statistics

  • CAGR (2024-2029) 20.3% CAGR
  • Market Size, 2024 ~USD 75.8 Million
  • Forecast, 2029 ~USD 190.7 Million
  • Country UK

UK Artificial Intelligence (AI) in Medical Diagnostics Market Overview

Market Valuation Growth :

The UK AI medical diagnostics market reached $75.8 million in 2024 and is forecast to grow to $190.7 million by 2029, demonstrating strong investor confidence and adoption across the healthcare sector.

Robust CAGR Performance :

At 20.3% CAGR, the UK market is experiencing accelerated growth driven by NHS digital transformation initiatives, regulatory support, and increasing deployment of AI diagnostic tools in clinical settings.

Healthcare Infrastructure Advantage :

The UK's advanced healthcare infrastructure, including the NHS's commitment to digital health and strong academic medical centres, creates an ideal environment for AI diagnostic innovation and commercialisation.

Investment & Innovation Hub :

Significant government and private sector investment in digital health technologies positions the UK as a leading centre for AI diagnostic development, attracting both domestic and international innovators.

UK Artificial Intelligence (AI) in Medical Diagnostics Market Dynamics

  • Healthcare providers are increasingly integrating AI technologies to improve diagnostic accuracy, reduce patient wait times, and optimise resource allocation across the healthcare system. Regulatory frameworks such as the MHRA's guidance on AI/ML-based software as a medical device are facilitating market entry and accelerating innovation.
  • Strategic partnerships between NHS trusts, technology companies, and academic institutions are fostering ecosystem development.
  • The convergence of improved data infrastructure, skilled talent pools, and supportive policy environments positions the UK market for sustained growth beyond 2029..

Related Ecosystem

Healthcare It

Top Technologies
  • Computed Tomography (CT)
  • Machine Learning
  • Magnetic Resonance Imaging (MRI)
  • Natural Language Processing (NLP)
  • Predictive Analytics
Top Companies
  • CERNER CORPORATION
  • PHILIPS HEALTHCARE
  • Oracle Corporation
  • GE HealthCare Technologies Inc.
  • Siemens healthineers

    Diagnostic Imaging

    Top Technologies
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • CT Scanners
    • Nuclear Imaging
    • Positron Emission Tomography
    Top Companies
    • Siemens healthineers
    • PHILIPS HEALTHCARE
    • CANON INC.
    • FUJIFILM Holdings Corporation
    • UNITED IMAGING HEALTHCARE CO., LTD.

      Key Takeaways

      • The UK AI medical diagnostics market is valued at $75.8 million in 2024 and will reach $190.7 million by 2029, growing at 20.3% CAGR.
      • The UK's NHS and private healthcare systems are major adopters of AI diagnostic tools, particularly in radiology, pathology, and oncology.
      • Regulatory support from MHRA and NICE guidance accelerates clinical validation and market adoption of AI solutions across the UK.
      • The UK's focus on real-world evidence and precision medicine integration positions it as a leader in AI diagnostic innovation within Europe.

      Artificial Intelligence (AI) in Medical Diagnostics Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment SERVICES (Component)
      Forecast Period 2024-2029
      Growth Rate CAGR of 22.5% from 2024 to 2029
      Largest Segment IN VIVO DIAGNOSTICS (Application)
      Market Size Base Year (Billions) ~USD 1.71 (2024)
      Revenue Forecast (Billions) ~USD 4.72 (2029)
      Segments Covered Component, Type, End User, Modality, Modality Type, Application, Type 2023-2029, Processor Type, Network Type, Type 2017-2022, Segment

      UK Artificial Intelligence (AI) in Medical Diagnostics Market Report Segmentation

      11 segment dimensions are covered across the global market.

      By Component

      • Hardware
      • Services
      • Software

      By Type

      • Adapter
      • Adapters
      • Asic
      • Autoimmune Testing
      • Blood Screening & Coagulation
      • Cardiology
      • Clinical Chemistry
      • Ct
      • Diagnostic Software
      • Endocrinology
      • Fpga
      • Gpu
      • Hematology
      • Imaging Software
      • Immunoassay
      • Infectious Disease
      • Interconnect
      • Interconnects
      • Mammography
      • Memory
      • Microbiology
      • Mpu
      • Mri
      • Network
      • Networks
      • Neurology
      • Obstetrics/Gynecology
      • Oncology
      • Ophthalmology
      • Other Diagnostic Modalities
      • Other Imaging Modalities
      • Other In Vitro Applications
      • Other In Vitro Diagnostics Applications
      • Other In Vivo Applications
      • Other In Vivo Diagnostics Applications
      • Predictive Analytics
      • Predictive Analytics Software
      • Processor
      • Processors
      • Radiology
      • Switch
      • Switches
      • Ultrasound
      • X Ray
      • X-Ray

      By End User

      • Diagnostic Imaging Centers
      • Diagnostic Laboratories
      • Hospitals
      • Other End Users

      By Modality

      • Clinical Chemistry
      • Diagnostic Modalities
      • Diagnostics Modality
      • Hematology
      • Imaging Modalities
      • Imaging Modality
      • Immunoassay
      • Microbiology
      • Other Diagnostic Modalities

      By Modality Type

      • Ct
      • Mammography
      • Mri
      • Other Modalities
      • Ultrasound
      • X-Ray

      By Application

      • In Vitro Diagnostics
      • In Vitro Diagnostics Applications
      • In Vivo Diagnostics
      • In Vivo Diagnostics Applications

      By Type 2023-2029

      • Cardiology
      • Neurology
      • Obstetrics/ Gynecology
      • Oncology
      • Ophthalmology
      • Other In Vivo Applications
      • Radiology

      By Processor Type

      • Asic
      • Fpga
      • Gpu
      • Mpu

      By Network Type

      • Adapter
      • Interconnect
      • Switch

      By Type 2017-2022

      • Cardiology
      • Neurology
      • Obstetrics/Gynecology
      • Oncology
      • Ophthalmology
      • Other In Vivo Applications
      • Radiology

      By Segment

      • Hardware Component

      UK: ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2023–2029

      Segment2023202420252026202720282029CAGR (%)
      DIAGNOSTIC IMAGING CENTERS14.217.221.125.430.335.541.219
      DIAGNOSTIC LABORATORIES4.24.967.18.49.711.117.5
      HOSPITALS41.751.464.178.795.3113.8134.421.2
      OTHER END USERS2.93.444.85.56.37.116.2
      TOTAL62.97795.2116139.5165.3193.820.3

      Target Audience

      • Healthcare Technology Vendors : AI diagnostic software and hardware manufacturers need UK market data to develop localised go-to-market strategies, understand NHS procurement processes, and identify partnership opportunities with healthcare providers.
      • NHS Trusts & Healthcare Providers : Hospital networks and diagnostic centres require market intelligence to evaluate AI solution providers, benchmark adoption rates, justify capital investments, and plan digital transformation roadmaps aligned with national priorities.
      • Investment & Private Equity Firms : Investors targeting UK healthtech need comprehensive market sizing, growth projections, and competitive dynamics to identify acquisition targets, portfolio companies, and high-potential investment opportunities in AI diagnostics.
      • Medical Device & Pharma Companies : Established pharmaceutical and medical device firms expanding into AI diagnostics require UK-specific market data to assess market entry feasibility, competitive positioning, and partnership strategies with NHS stakeholders.
      • Policy Makers & Regulatory Bodies : Government agencies and health authorities need market research to inform digital health policy, funding allocation, regulatory framework development, and strategic planning for AI integration across the UK healthcare system.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise UK market valuation data ($75.8M in 2024) and verified five-year forecasts to support investment decisions, business planning, and competitive positioning in the rapidly expanding AI diagnostics sector.
      • UK-Specific Regulatory Insights : Understand MHRA approval pathways, NHS procurement requirements, and UK-specific compliance frameworks essential for product development, market entry strategy, and regulatory navigation.
      • Competitive Landscape Analysis : Identify key UK players, emerging startups, and international competitors establishing operations in Britain, enabling strategic partnerships, acquisition targets, and differentiation opportunities.
      • NHS Integration Opportunities : Discover NHS trust adoption patterns, digital transformation budgets, and procurement channels critical for healthcare providers and technology vendors seeking to scale AI diagnostic solutions across the UK health system.
      • Investment & Funding Intelligence : Access data on UK venture capital activity, government grants, and private equity interest in AI diagnostics to identify funding sources, investor networks, and growth capital opportunities specific to the British market.

      Frequently asked questions

      What is the current size of the UK AI medical diagnostics market?

      The UK AI medical diagnostics market was valued at $75.8 million in 2024 and is expected to grow to $190.7 million by 2029.

      What is the growth rate of the UK AI medical diagnostics market?

      The UK market is growing at a compound annual growth rate (CAGR) of 20.3% from 2024 to 2029.

      Which healthcare sectors in the UK are driving AI diagnostic adoption?

      The UK's NHS and private healthcare providers are leading adoption in radiology, pathology, oncology, and cardiology diagnostics.

      What regulatory bodies oversee AI diagnostics in the UK?

      The UK Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) provide regulatory oversight and clinical guidance for AI diagnostic tools.

      How does the UK market compare to global AI diagnostics growth?

      The UK's 20.3% CAGR is slightly below the global average of 22.5%, reflecting the UK's mature healthcare market and established adoption pathways.

      RESEARCH METHODOLOGY

      To balance primary and secondary research for the AI in Medical Diagnotics market, different market variables for small and medium-sized businesses and major businesses were analyzed as part of this study. The next step involved primary research with industry experts along the value chain to validate these findings, assumptions, and market sizing. Many different methodologies were used for estimating the overall market size, involving the top-down and bottom-up approaches. The study consists of significant market segments, evolving patterns, regulatory frameworks, and competitive environments. This study also considers leading market players and the strategies they deploy in this market. In conclusion, the total market size was estimated through top-down and bottom-up approaches along with data triangulation to reach the number for the final market size. Primary research was conducted throughout the study to validate and test each hypothesis.

      Secondary Research

      The secondary sources referred to for this research study include publications from government sources, directories, and databases (Dun & Bradstreet, Bloomberg Businessweek, and Factiva, among others) to identify and collect information useful for the technical, market-oriented, and commercial study of AI in medical diagnostics market. Secondary data was collected and analyzed to arrive at the overall size of the global AI in medical diagnostics market, which was validated through primary research.

      Primary Research

      Extensive primary research was conducted after acquiring basic knowledge about the global of AI in medical diagnostics market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Hospitals, Clinics and Other Healthcare Facilities, Diagnostic laboratories and Diagnostics Imaging Center, Other End Users- Employer Groups and Government Bodies) and supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, and Rest of the world. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

      AI in Medical Diagnostics Market

      Note 1: C-level primaries include CEOs, CFOs, and COOs.

      Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note 3: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      As per the review of prominent companies and their revenue shares, the market size of the global AI in medical diagnostics market was calculated in this report. Key players with significant shares in the market were identified as part of secondary research and their medical diagnostics business revenue was calculated, primaries validated the same. Analyzing the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, in-depth interviews with important thought leaders, including directors, CEOs, and marketing executives, were a part of the primary study.

      Both top-down and bottom-up approaches were used to estimate and validate the size of the AI in medical diagnostics market and various other dependent submarkets. The research methodology used to estimate the market size includes the following details:

      • Revenues of individual companies were gathered from public sources and databases
      • The shares of the AI in medical diagnostics market players were gathered from secondary sources to the extent available. In certain cases, the shares of the businesses were ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling prices, and geographic reach and strength
      • Individual shares or revenue estimates were validated through expert interviews
      • All percentage shares, splits, and breakdowns for the global AI in medical diagnostics market were determined by using secondary sources and verified through primary sources
      • All key macro indicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get validated and verified quantitative and qualitative data
      • The gathered market data was consolidated and added with detailed inputs and analysis and presented in this report

      AI in medical diagnostics Market Size: Market Estimation Approach

      AI in Medical Diagnostics Market

      Data Triangulation

      To estimate the overall market size of the AI in medical diagnostics market, a detailed market size estimation process was followed. The market was then segmented into various segments and subsegments for more precise analysis. To ensure accuracy, data triangulation and market breakdown methodologies were applied where applicable. This approach involved analyzing various factors and trends from both the demand and supply sides, providing comprehensive and reliable insights into the market.

      Market Definition

      Artificial intelligence (AI) refers to the theory and development of computer systems capable of performing tasks that usually require human intelligence. AI involves the study & synthesis of intelligent agents—in this case, a computer system. The system perceives its environment and takes appropriate action to maximize success. AI is being developed to create expert systems and improve human intelligence in machines.

      AI is used in the medical diagnostics market to analyze complex data from various imaging modalities and help end users interpret critical data points to diagnose disease conditions.

      Stakeholders

      • Hospitals
      • Diagnostic care centers
      • Diagnostic laboratories
      • Radiologists and radiology clinics
      • Diagnostic imaging AI device manufacturers and suppliers
      • Medical research laboratories
      • Academic medical centers and universities

      Report Objectives

      • To define, describe, and forecast artificial intelligence in the medical diagnostics market based on component, application, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning four main regions—North America, Europe, the Asia Pacific, and the Rest of the World (RoW)2
      • To profile the key players and comprehensively analyze their market shares and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches/enhancements, expansions, agreements, collaborations, partnerships, and approvals in AI medical diagnostics market

       

      Get the Full Artificial Intelligence (AI) in Medical Diagnostics Market Report

      Full forecast, segment splits, and company analysis for all Artificial Intelligence (AI) in Medical Diagnostics Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status